Exchange: OTC·Updated 08:04 AM EDT

ORPOF OSE Immunotherapeutics

$4.43
$1.43
(32.25%)
Pre-Market
Prev Close $4.43
EarningsOct 15
Mkt Cap$104.19M
Vol800.00

About ORPOF

OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
50

Neutral Sentiment

How do you feel about ORPOF?

Advertisement|Remove ads.